NCT06798688Not yet recruiting
In This Study, the Sponsor Would Like to Collaborate with Institution and Investigator to Aggregate Participants Data and to Pilot Its Software Algorithm Using Machine Learning and Threshold Based Methods for Predicting Exacerbations and Deterioration Within a 60 Days Period Post-discharge
Software Algorithm Using Machine Learning and Threshold Based Methods for Predicting Exacerbations and Deterioration
Source: ClinicalTrials.gov · Last updated 29 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In this study, the sponsor would like to collaborate with Institution and Investigator to aggregate participants data and to pilot its software algorithm using machine learning and threshold based methods for predicting exacerbations and deterioration within a 60 days period post-discharge.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 22 Jan 2025
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Jul 2025
- Lead sponsor
- Respiree Pte Ltd
- Diseases
- COPD
- NCT number
- NCT06798688
What you commit to
- Study type: Observational
- Planned participants: 20
- From 1 Mar 2025 to the primary completion date, 1 Jul 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants with neuromuscular diseases and seizures
Other
- Participants enrolled in hospice care or life expectancy less than three months.
- Participants living more than 60 miles away from Institution and Investigator
- Participants with expected out of state travel within a 30-day period or travel to a location with no internet access.
Who the study is looking for
- Subject age 18 or older
- Receives all primary and specialty care at Institution
- Participants will be enrolled at discharge (and not designate hospital or ED)
- A history of one of the following diagnoses:
- c. Chronic obstructive pulmonary disease
- At least two documented exacerbations of the above disease in the past 12 months as defined by the following corresponding criteria:
- Chronic obstructive pulmonary disease exacerbation: all three of (1) increase in frequency and severity or severity of cough, (2) increase in volume and/or change of character of sputum production, and (3) increase in dyspnea, and requiring treatment with short-acting bronchodilators, antibiotics, and oral or intravenous glucocorticoids.
- Participants able to provide informed consent.
- Participants will be enrolled at discharge (and not designate hospital or ED)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.